Richard W. Pascoe

2019 - Conatus Pharmaceuticals

In 2019, Richard W. Pascoe earned a total compensation of $2.1M as President, Chief Executive Officer Director at Conatus Pharmaceuticals.

Compensation breakdown

Option Awards$1,657,632
Salary$422,884
Total$2,080,516

Pascoe received $1.7M in option awards, accounting for 80% of the total pay in 2019.

Pascoe also received $422.9K in salary.

Rankings

In 2019, Richard W. Pascoe's compensation ranked 5,727th out of 13,971 executives tracked by ExecPay. In other words, Pascoe earned more than 59.0% of executives.

ClassificationRankingPercentile
All
5,727
out of 13,971
59th
Division
Manufacturing
2,146
out of 5,701
62nd
Major group
Chemicals And Allied Products
774
out of 2,200
65th
Industry group
Drugs
651
out of 1,886
66th
Industry
Pharmaceutical Preparations
478
out of 1,398
66th
Source: SEC filing on April 15, 2021.

Pascoe's colleagues

We found two more compensation records of executives who worked with Richard W. Pascoe at Conatus Pharmaceuticals in 2019.

2019

Steven Mento

Conatus Pharmaceuticals

Chief Executive Officer

2019

Gail Naughton

Conatus Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like